Halix to provide drug substance for AstraZeneca COVID-19 vaccine candidate

MOSCOW (MRC) -- Halix (Leiden, Netherlands), a biopharmaceutical contract development and manufacturing organization (CDMO), says it has signed an agreement with AstraZeneca to provide large-scale commercial manufacturing of drug substance AZD1222 for the COVID-19 vaccine candidate co-invented by the University of Oxford, UK, and its spin-out company Vaccitech, said Chemweek.Halix says i

Full article at mrcplast.com